Talkspace IncTALK
Price$5.25

Valuation

How Intrinsic Value compares with model outputs

Intrinsic Value Insufficient data for a value estimatebased on filings through 31 Dec 2025
Market Price $5.25Price as of 14 Aug 2026
Data confidenceNot applicable

Valuation methods vs. Market Price

Company vs. peer median Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions

ParameterValue
Years 1–5: analyst growth pathFive-year total matches analyst consensus exactly. Year 1: 60.0% (near-term consensus, capped) · years 2–5: 6.3%/yr (balance of the path).15.4% per year
Years 6–10: glide to demonstrated growth
Per-year rates
Yr 65.6%Yr 75.0%Yr 84.3%Yr 93.7%Yr 103.0%
6.3% → 3.0%
Years 11–20: glide to long-run rate
Per-year rates
Yr 113.0%Yr 123.0%Yr 133.0%Yr 143.0%Yr 153.0%Yr 163.0%Yr 173.0%Yr 183.0%Yr 193.0%Yr 203.0%
3.0% → 3.0%
Beyond year 20: terminal growthPerpetual long-run rate3.0%
Discount rate (cost of equity) 9.7%
Volatility vs market (adjusted beta)1.05

Valuation Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Compare with peers

Search any company to compare valuation, profitability, returns, growth, and financial strength side by side.

Compare the target company plus 1 peer. Sign in / Sign up to compare a maximum of 3 peers.

Best in rowHigher is betterLower is better—Data not available
TargetTalkspace IncTALKHealth Care
Valuation
P/E—
P/S3.8×
P/B7.5×
EV / Revenue3.6×
EV / EBITDA899.4×
Profitability
Gross margin43.0%
Operating margin1.4%
Net margin3.4%
FCF margin3.7%
Returns
ROE6.7%
ROA5.6%
ROIC9.8%
Growth
Revenue growth (YoY)22.0%
5-yr fwd EPS growth—
Financial strength
Debt / Equity0.00×
Current ratio—
Altman Z-Score—
Interest coverage—
Dividend yield—

Best value in each row is highlighted. Figures are periodic snapshots from the same filings used across each dossier; a dash means the figure is not available.

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.